Prince Pharmaceutical Co., Ltd. (TPEX:6935)
Taiwan · Delayed Price · Currency is TWD 28.20
+1.35 (5.03%)
Nov 10, 2026, 1:53 PM CST
Prince Pharmaceutical Market Cap
Prince Pharmaceutical has a market cap or net worth of 1.05 billion as of November 10, 2026. It is the 33,241st most valuable company in the world and the 1,986th biggest in Taiwan. Its market cap has decreased by 7.03% in one year.
Market Cap
1.05B
Enterprise Value
1.39B
Revenue
1.22B
Global Rank
Country Rank
#1,986 Taiwan
PE Ratio
8.10
ChartMarket Cap Chart
Since March 29, 2023, Prince Pharmaceutical's market cap has decreased from 1.94B to 1.05B, a decrease of -45.72%. That is a compound annual growth rate of -15.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 1.05B | -7.33% |
| Dec 31, 2025 | 1.14B | 42.01% |
| Dec 31, 2024 | 801.65M | -36.72% |
| Dec 29, 2023 | 1.27B | -34.82% |
| Mar 29, 2023 | 1.94B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PhytoHealth | 2.11B |
| Johnson Chemical Pharmaceutical Works | 1.77B |
| Tien Liang BioTech | 1.58B |
| InnoPharmax | 1.13B |
| GeneFerm Biotechnology | 1.12B |
| Excelsior Biopharma | 1.11B |
| Anxo Pharmaceutical | 951.50M |
| DV Biomed | 881.44M |